Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charter Communications
CHTR
|
+$601M |
| 2 |
Parker-Hannifin
PH
|
+$576M |
| 3 |
JPMorgan Chase
JPM
|
+$575M |
| 4 |
Goldman Sachs
GS
|
+$452M |
| 5 |
FedEx
FDX
|
+$371M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$733M |
| 2 |
American Tower
AMT
|
+$684M |
| 3 |
Nike
NKE
|
+$601M |
| 4 |
AGN
Allergan plc
AGN
|
+$561M |
| 5 |
McDonald's
MCD
|
+$536M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.24% |
| 2 | Consumer Discretionary | 17.64% |
| 3 | Healthcare | 13.82% |
| 4 | Communication Services | 12.12% |
| 5 | Financials | 11.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FRC
101
DELISTED
First Republic Bank
FRC
| $147M | 0.16% |
1,598,313
-295,932
| -16% | -$24.2M |
|
|
AY
102
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
| $147M | 0.16% |
7,597,607
-392,536
| -5% | -$7.16M |
|
103
DTE Energy
DTE
$28.3B
| $146M | 0.16% |
1,743,808
-64,747
| -4% | -$5.21M |
|
104
RTX Corp
RTX
$285B
| $146M | 0.16% |
2,109,453
+309,221
| +17% | +$20.5M |
|
|
CONE
105
DELISTED
CyrusOne Inc Common Stock
CONE
| $143M | 0.16% |
3,188,260
-287,251
| -8% | -$12.7M |
|
106
Carnival Corporation Ltd
CCL
$33.9B
| $142M | 0.16% |
2,720,580
-282,018
| -9% | -$14.1M |
|
107
Amphenol
APH
$194B
| $141M | 0.16% |
8,422,212
-2,903,372
| -26% | -$48.4M |
|
|
FTR
108
DELISTED
Frontier Communications Corp.
FTR
| $140M | 0.16% |
2,768,890
-54,108
| -2% | -$2.97M |
|
|
SAVE
109
DELISTED
Spirit Airlines, Inc.
SAVE
| $140M | 0.16% |
2,417,539
-943,997
| -28% | -$48.7M |
|
|
SEMG
110
DELISTED
SEMGROUP CORPORATION
SEMG
| $138M | 0.15% |
3,297,512
+109,800
| +3% | +$3.93M |
|
111
Ametek
AME
$54.2B
| $137M | 0.15% |
2,824,071
+299,434
| +12% | +$14.2M |
|
112
East-West Bancorp
EWBC
$17.7B
| $135M | 0.15% |
2,660,420
+24,419
| +0.9% | +$1.09M |
|
113
CBRE Group
CBRE
$43.7B
| $132M | 0.15% |
4,189,075
-287,972
| -6% | -$8.34M |
|
114
UnitedHealth
UNH
$353B
| $131M | 0.15% |
818,784
+42,987
| +6% | +$6.42M |
|
|
AERI
115
DELISTED
Aerie Pharmaceuticals
AERI
| $130M | 0.14% |
3,428,860
-135,385
| -4% | -$5.12M |
|
116
Merck
MRK
$366B
| $130M | 0.14% |
2,308,160
-252,192
| -10% | -$14.8M |
|
117
Eli Lilly
LLY
$1.05T
| $128M | 0.14% |
1,735,410
+441,381
| +34% | +$32.9M |
|
118
Affiliated Managers Group
AMG
$9.59B
| $127M | 0.14% |
874,733
-28,997
| -3% | -$4.21M |
|
119
Procter & Gamble
PG
$334B
| $127M | 0.14% |
1,508,629
-285,857
| -16% | -$24.4M |
|
120
Crown Castle
CCI
$32.4B
| $126M | 0.14% |
1,455,058
-539,991
| -27% | -$47.3M |
|
121
Texas Instruments
TXN
$236B
| $125M | 0.14% |
1,719,319
-16,792
| -1% | -$1.2M |
|
|
INFO
122
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $125M | 0.14% |
3,533,357
-466,688
| -12% | -$16.8M |
|
123
PTC
PTC
$17.1B
| $123M | 0.14% |
2,657,698
-431,192
| -14% | -$20.2M |
|
124
American Electric Power
AEP
$66.6B
| $123M | 0.14% |
1,952,072
-62,542
| -3% | -$3.86M |
|
|
EA
125
DELISTED
Electronic Arts
EA
| $123M | 0.14% |
1,559,578
-854,415
| -35% | -$68.7M |
|
Similar funds
Jennison Associates's Q4 2016 Portfolio in Review
As of Q4 2016, Jennison Associates held 857 positions worth $89.6B, down 3.4% from $92.8B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Jennison Associates withdrew a net $3.79B in Q4 2016, closing 52 positions and reducing 313 holdings. Its most notable exit was lululemon athletica, an estimated $342M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Jennison Associates opened a new position in Parker-Hannifin worth $606M.
- Jennison Associates's largest Q4 2016 buy was Parker-Hannifin: 4,330,276 shares worth $606M.
- Jennison Associates added most to Charter Communications in Q4 2016, an estimated $601M increase.
- Jennison Associates's biggest Q4 2016 reduction was Biogen, cutting an estimated $733M.
- Jennison Associates fully exited lululemon athletica in Q4 2016, selling an estimated $342M.
- Jennison Associates's ten largest holdings make up 25% of its $89.6B portfolio in Q4 2016.
- Jennison Associates opened 208 new positions and closed 52 in Q4 2016.
- Jennison Associates's portfolio value fell 3.4% quarter-over-quarter to $89.6B.
Based on Jennison Associates's 13F filing for Q4 2016, filed 6 Feb 2017.